Is GlaxoSmithKline a Great Dividend Stock?
The pharmaceutical giant recently cut its dividend, but it still pays a better yield than most in the industry.
3 Ultra-High-Growth Biopharma Stocks to Grab Now
Can the run for Sarepta Therapeutics, Viela Bio, and Aptose Biosciences continue?
Zynex Soared Last Week. But Is It a Risky Buy?
Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.
These 2 Stocks Are Cleaning Up Thanks To Medical Mask Sterilization. Are They Buys?
Steris and Fortive are on the rise, thanks in part to their medical devices used to decontaminate N95 or N95-equivalent respirators.
3 Pot Stocks to Stay Miles Away From
There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.
Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?
The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?
4 Hot Dividend Stocks Yielding More Than 6%
They all pay handsomely to income-conscious investors and have sustainable payouts.
Is Cresco Labs a Risky Buy?
The Chicago company's growth may allow it to be a cannabis survivor. Here's what investors need to know.
Better Buy: AbbVie vs. Johnson & Johnson
Which of these pharmaceutical giants is more likely to provide investors with big gains in 2020?
Got $1,000? Buy These 3 Medical Distributor Stocks
These three companies dominate the industry, and all provide growth with a nice dividend.
3 Stocks to Buy Ahead of the Next Market Crash
The global pandemic has shown us that certain stocks do better than others coming out of a market decline.
Is It Too Late to Jump In on Zentalis?
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
3 Pet Med Stocks That Offer Growth and a Nice Dividend
Spending on pet health continues to climb. Investors should consider buying PetMed Express, Phibro Animal Health, and Merck & Co.
Why Align Technology Remains a Good Investment Opportunity
The maker of Invisalign aligners had a tough first quarter because of the COVID-19 pandemic, but the company is poised for a breakout.
Hologic Is Trading Near Its All-Time High. Is It Still a Good Buy?
The company's COVID-19 testing platform is just part of the reason for the stock's jump.
3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking Off
A hot new migraine drug, positive financials, and several promising drug candidates in late-stage trials are luring investors to this stock.
3 Medical-Supply Stocks You Should Own Besides Medtronic
MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.
FDA Approval Could Be a Game-Changer for Deciphera Pharmaceuticals
Approval of its cancer-fighting drug could make all the difference.
Will Good News Boost This Small-Cap Drug Company's Stock Even Higher?
A do-over on one of its drugs is a potential game-changer for CymaBay.
Is Green Thumb Worth a Second Look?
With climbing revenue and lowered losses, this company may be a cannabis survivor.